The Guardian - Pharmaceutical Industry

AUGUST 14, 2024

Chancellor reportedly seeking to cut £20m from the £65m promised by Hunt to Merseyside manufacturing plant Business live – latest updates A £450m plan to expand an AstraZeneca vaccine-manufacturing site in Merseyside has suffered a blow after it emerged the government plans to cut some of the funding for the scheme. Continue reading.

Vaccines 104

Vaccines Pharmaceutical Companies Pharmaceutical Companies 104

European Pharmaceutical Review

OCTOBER 6, 2023

Positive interim results from Moderna’s Phase I/II trial of mRNA-1083 , an investigational vaccine designed to immunise against both influenza and COVID-19, have been released. There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 97

Pharmaceutical Technology

JUNE 20, 2023

The World Health Organisation (WHO) has granted an emergency use listing (EUL) to SK bioscience’s Covid-19 vaccine, SKYCovione. SKYCovione is a self-assembled nanoparticle vaccine and the 12th Covid-19 vaccine to receive a EUL from the regulator.

Vaccines 145

Vaccines Pharmaceutical Companies Pharmaceutical Companies 145

STAT

AUGUST 17, 2023

A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 22, 2023

The Food and Drug Administration approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people, STAT tells us. The vaccine, marketed as Abrysvo, previously won approval for adults over the age of 60.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 98

pharmaphorum

SEPTEMBER 6, 2022

The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s acceptance of advice from the Joint Committee on Vaccination and Immunisation (JCVI) to go ahead with rollout of Pfizer’s bivalent 30mg booster shot this week. million)” during the first year of vaccinations.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

The Guardian - Pharmaceutical Industry

JANUARY 27, 2025

Collaboration over at least three years aims to help understand how pre-cancerous cells develop Business live latest updates GSK has said it will spend 50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers. Continue reading.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies 78

STAT

OCTOBER 19, 2022

” But when vaccines to prevent the disease were developed, those same leaders pushed low and middle-income countries to the back of the queue, outbidding poorer countries, as well as COVAX, a worldwide initiative developed to achieve equitable vaccine access, to secure vaccines for themselves.

Vaccines 120

Vaccines Pharmaceutical Companies Pharmaceutical Companies 120

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccines 96

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 96

The Guardian - Pharmaceutical Industry

AUGUST 28, 2024

Earlier this year, there was an outcry when it appeared that a doctor who often appeared on TV to speak about Covid vaccines had been paid a significant sum by the pharmaceutical company AstraZeneca. The payment was to promote a flu vaccine, not the Covid vaccine. Independence matters.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies 111

Pharmafile

MAY 9, 2024

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in global demand. The withdrawal also comes after AstraZeneca admitted in court documents that the vaccine can cause thrombosis with thrombocytopenia syndrome (TTS).

Vaccines 59

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 59

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing.

Pharmaceutical Companies 133

Pharmaceutical Companies Pharmaceutical Companies Vaccines 133

European Pharmaceutical Review

AUGUST 31, 2023

Even with extremely rapid vaccine development, limitations in production capabilities can have real-life implications. This has led pharmaceutical equipment manufacturers to react quickly, while maintaining due levels of diligence and social responsibility.

Vaccines 104

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 104

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Hospitals 98

pharmaphorum

MAY 5, 2021

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling medicines. . The vaccine made $3.5 The vaccine made $3.5 Spending and profit from the vaccine are split equally between Pfizer and BioNTech.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 105

STAT

MAY 28, 2024

… Almost a dozen pharmaceutical companies have lost sensitive customer data due to a supply chain cyberattack that trickled down from Cencora , TechRadar writes. These data are crucial for rapid development of diagnostic tests, vaccines, and treatments. Our choice today is hot buttery rum. Either way, do keep in touch.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies 111

pharmaphorum

JANUARY 31, 2022

Daiichi Sankyo has stepped up its efforts to bring a Japanese COVID-19 vaccine to patients, starting a new clinical trial of its mRNA-based candidate DS-5670 that focuses on its use as a booster dose. The Japanese group says it hopes to complete clinical development of the vaccine and bring it to market in Japan before the end of the year.

Vaccines 96

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 96

STAT

DECEMBER 13, 2024

Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2 Just 9% came from the private sector, such as pharmaceutical companies. billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies Vaccines 100

Pharma Mirror

SEPTEMBER 11, 2022

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

STAT

JULY 30, 2024

… Four pharmaceutical companies involved in the negotiations over prices for Medicare do not expect a significant impact on their businesses after seeing confidential suggested prices from the government for their drugs that will take effect in 2026 , Reuters writes. Meanwhile, here are a few items of interest.

Vaccines 103

Vaccines Pharmaceutical Companies Pharmaceutical Companies 103

STAT

SEPTEMBER 14, 2022

… For pharmaceutical companies, online prescribing has now become a powerful tool to drive sales, sending hundreds of thousands of patients to the clinic at the moment they are most primed to ask for a specific prescription, STAT reports. Remember that no prescription is required — so no co-pay or rebate is involved.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

European Pharmaceutical Review

OCTOBER 23, 2023

Janssen Pharmaceutical Companies of Johnson & Johnson’s data were featured at the European Society for Medical Oncology (ESMO) 2023 Congress. coli vaccine The post ESMO 2023: Janssen reveals data for intravesical delivery system appeared first on European Pharmaceutical Review.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Vaccines Hospitals 111

Pharma Times

OCTOBER 1, 2021

The European Patent Office (EPO) has granted a patent to specialist pharmaceutical company, N4 Pharma, for its Nuvec cancer treatment and vaccine delivery system.

Vaccines 49

Vaccines Pharmaceutical Companies Pharmaceutical Companies 49

pharmaphorum

MARCH 22, 2021

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. It is not only COVID-19 vaccines and therapeutics that benefit from a more regionalised approach. About the author. Dr Subir K.

Vaccines 122

Vaccines Dosage Pharmaceutical Companies Pharmaceutical Companies 122

pharmaphorum

FEBRUARY 25, 2022

The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic. This momentum with collaboration and partnership, both with other companies within the industry, as well as external bodies, cannot be lost.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Patient Care 98

pharmaphorum

APRIL 8, 2020

This pharmaphorum webinar will take place on 8th April and comes as the COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine. So, what is technology’s role in supporting the faster evaluation of vaccines?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 21, 2022

The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this. The result of the improving knowledge of vaccines’ role in society initially led to a rise in interest in receiving a COVID-19 vaccine.

Vaccines 98

Vaccines Immunization Compounding Pharmaceutical Companies 98

European Pharmaceutical Review

NOVEMBER 16, 2022

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. The research showed 83 percent of pharmaceutical companies are putting more strategies in place.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 98

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Coronavirus vaccine components. The vaccine also contains other inactive ingredients such as cholesterol.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunization 52

pharmaphorum

DECEMBER 21, 2021

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 115

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Flavivirus vaccine components. Sanofi is one of the leading patent filers for Flavivirus vaccine components.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunization 52

ISPE

SEPTEMBER 21, 2022

However, the global public health driver to execute these projects in record time, and deliver commercially approved vaccines, in large volumes, was unprecedented and therefore deserves recognition for Social Impact. Janssen Biologics provides clinical and commercial manufacturing services of complex medicines and vaccines.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies 97

The Checkup by Singlecare

APRIL 6, 2023

Vaccines have been an essential part of protecting public health for decades. However, despite the overwhelming evidence for their effectiveness and safety, there has been an increasing trend of vaccine hesitancy in recent years. What is vaccine hesitancy? Are there any long-term risks with vaccines?

Vaccines 52

Vaccines Immunization Communication Pharmaceutical Companies 52

pharmaphorum

JUNE 1, 2022

Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further. The more you know.

Vaccines 145

Vaccines Immunization Hospitals Packaging 145

ISPE

NOVEMBER 2, 2022

Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Pfizer “cleared runway to allow for large-scale vaccine manufacturing before we had a product!”

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98